Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial hepatic administration of SIR-Spheres for advanced hepatocellular carcinoma (Phase II)
2005-005183-82Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Feb 2006
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
A Phase 2 trial of yttrium-90 in hepatocellular carcinoma (HCC), sponsored by Sant'Orsola-Malpighi University Hospital. Started Feb 2006; status: completed.
02
Drugs
yttrium-90
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2005-005183-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005183-82.